LEP and inflammatory bowel disease: Altered adipocyte function and deregulated production of adipokines, such as leptin, adiponectin, resistin, and proinflammatory cytokines (IL-6, TNF-α), leads to chronic inflammation that may predispose an obese individual to IBD, mainly CD.